Icosapent Ethyl
- Product NDC
- 71335-3072
- 11-digit product format
- 713353072
- Labeler code
- 71335
- Product ID
- 71335-3072_c5b955ca-a0c6-4785-8796-7ec9ef54cd7b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Icosapent Ethyl
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209457
- Marketing category
- ANDA
- Marketing start
- 2020-11-04
- Substance
- ICOSAPENT ETHYL
- Active strength
- 1 g/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209457-001 | ICOSAPENT ETHYL | ICOSAPENT ETHYL | 1GM | CAPSULE / ORAL | AB | 2020-05-21 | |
| A209457-002 | ICOSAPENT ETHYL | ICOSAPENT ETHYL | 500MG | CAPSULE / ORAL | AB | 2023-03-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209457-001 | AB |
| A209457-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209457-001 | ICOSAPENT ETHYL | 1GM | CAPSULE / ORAL | AB | 2020-05-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209457-002 | ICOSAPENT ETHYL | 500MG | CAPSULE / ORAL | AB | 2023-03-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209457-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209457-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Icosapent Ethyl | ICOSAPENT ETHYL | Northstar Rx LLC | 45f8bb41-bdb1-4afc-83ec-9dc69720ee9c | 2026-07-29 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Hikma Pharmaceuticals USA Inc. | e3d38d1d-fbe7-413d-849a-675e7dfa9b0a | 2026-07-09 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | 07631e74-48e5-46ec-b8db-4b1bcf62d283 | 2026-02-09 | Warnings, Adverse reactions | 209457 ANDA209457 71335-3072 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | 582638e5-9881-409d-a455-041b5ba6892a | 2025-10-21 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | 0ee78f22-bed2-48f8-9be8-b8f6ceeeaeaf | 2024-12-24 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | f9c1a6a6-cda4-49ea-97e9-0d3cf5ab5d4c | 2024-01-15 | Warnings, Adverse reactions | 209457 ANDA209457 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Icosapent Ethyl
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ICOSAPENT ETHYL | 1 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6GC8A4PAYH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1304979 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 07631e74-48e5-46ec-b8db-4b1bcf62d283 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f6766515-27b8-72de-2010-167151236ace | Product name | 7 | 20251021 |
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-3072-1 | Icosapent Ethyl | 30 in 1 BOTTLE | CAPSULE | 30 | 1 | |
| 71335-3072-2 | Icosapent Ethyl | 60 in 1 BOTTLE | CAPSULE | 60 | 1 | |
| 71335-3072-3 | Icosapent Ethyl | 120 in 1 BOTTLE | CAPSULE | 120 | 1 | |
| 71335-3072-4 | Icosapent Ethyl | 90 in 1 BOTTLE | CAPSULE | 90 | 1 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1304979 | icosapent ethyl 1 GM Oral Capsule | PSN | 07631e74-48e5-46ec-b8db-4b1bcf62d283 | 1 |
| 1304979 | icosapent ethyl 1000 MG Oral Capsule | SCD | 07631e74-48e5-46ec-b8db-4b1bcf62d283 | 1 |
| 1304979 | icosapent ethyl 1 GM Oral Capsule | SY | 07631e74-48e5-46ec-b8db-4b1bcf62d283 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71335-3072-1 | 71335307201 | 30 CAPSULE in 1 BOTTLE (71335-3072-1) | 30 capsule | 2026-02-09 | No | No | Current |
| 71335-3072-2 | 71335307202 | 60 CAPSULE in 1 BOTTLE (71335-3072-2) | 60 capsule | 2026-02-09 | No | No | Current |
| 71335-3072-3 | 71335307203 | 120 CAPSULE in 1 BOTTLE (71335-3072-3) | 120 capsule | 2026-02-09 | No | No | Current |
| 71335-3072-4 | 71335307204 | 90 CAPSULE in 1 BOTTLE (71335-3072-4) | 90 capsule | 2026-02-09 | No | No | Current |